B3GAT1 and neoplasm: Therapeutic interventions based on other cell surface molecules on neuroblastoma, including 4Ig-B7-H3 (89) and CD57 (90, 91), might be worth investigating, although these molecules are known to be expressed on both the tumor cells and immune cells.